What is she best known for?
The fields of study she is best known for:
The scientist’s investigation covers issues in Genetics, Gene, Germline mutation, Adenocarcinoma and Mutation.
Her research related to Genome, Human genome, Exome, Mutation rate and Somatic cell might be considered part of Genetics.
As a part of the same scientific study, Carrie Sougnez usually deals with the Genome, concentrating on Exome sequencing and frequently concerns with Genomics and Cancer.
When carried out as part of a general Gene research project, her work on Tumor suppressor gene is frequently linked to work in Oncogene, therefore connecting diverse disciplines of study.
Her Germline mutation study integrates concerns from other disciplines, such as Molecular biology, Adenocarcinoma of the lung and MET Exon 14 Skipping Mutation.
Her Mutation study incorporates themes from Mesenchymal Glioblastoma, Phenotype, Telomerase and DNA methylation.
Her most cited work include:
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity (4467 citations)
- Mutational heterogeneity in cancer and the search for new cancer-associated genes (3432 citations)
- Comprehensive molecular characterization of gastric adenocarcinoma (2822 citations)
What are the main themes of her work throughout her whole career to date?
Carrie Sougnez spends much of her time researching Genetics, Exome sequencing, Cancer research, Mutation and Germline mutation.
Her Genetics study is mostly concerned with Exome, Cancer, Gene, Genome and Point mutation.
Her Gene research is multidisciplinary, incorporating perspectives in Computational biology and Adenocarcinoma.
Carrie Sougnez interconnects Bioinformatics, Somatic cell, KRAS, Neuroblastoma RAS viral oncogene homolog and PTEN in the investigation of issues within Cancer research.
The Mutation study combines topics in areas such as Molecular biology, Chronic lymphocytic leukemia, Loss of heterozygosity and Somatic evolution in cancer.
In her research on the topic of Germline mutation, Histone methylation is strongly related with Cancer genome sequencing.
She most often published in these fields:
- Genetics (62.50%)
- Exome sequencing (27.88%)
- Cancer research (27.88%)
What were the highlights of her more recent work (between 2013-2019)?
- Genetics (62.50%)
- Cancer research (27.88%)
- Mutation (26.92%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Genetics, Cancer research, Mutation, Exome sequencing and Somatic evolution in cancer.
Her study in Genetics concentrates on DNA sequencing, [email protected], Human genome, Gene and Bisulfite sequencing.
She combines subjects such as Bioinformatics, Somatic cell, Point mutation, Monoubiquitination and Adenocarcinoma with her study of Cancer research.
The study incorporates disciplines such as Genetic heterogeneity and Exome in addition to Bioinformatics.
Her work in Somatic cell tackles topics such as Germline mutation which are related to areas like MLH1.
Her research integrates issues of Whole genome sequencing and Massive parallel sequencing in her study of Mutation.
Between 2013 and 2019, her most popular works were:
- Comprehensive molecular characterization of gastric adenocarcinoma (2822 citations)
- Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
- Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy (599 citations)
In her most recent research, the most cited papers focused on:
Her primary scientific interests are in Cancer research, Bioinformatics, Somatic cell, Genetic heterogeneity and Germline mutation.
Her Cancer research research incorporates themes from CpG Island Methylator Phenotype, MLH1 and Lynch syndrome.
Her Bioinformatics study frequently draws parallels with other fields, such as Exome.
Her Exome study necessitates a more in-depth grasp of Mutation.
Her research in Germline mutation intersects with topics in MET Exon 14 Skipping Mutation, DNA mismatch repair and Adenocarcinoma.
Her Adenocarcinoma of the lung study in the realm of Adenocarcinoma connects with subjects such as Oncogene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
